Rezolve Ai criticizes Commerce.com poison pill adoption
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Medifast launches Trilivy, replacing its Optavia brand
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
Rezolve Ai Slams Commerce.com Board’s "Desperate" Poison Pill That Will Dilute Shareholders and Stagnate Growth Further
April 14, 2026 1:32 PM EDTLabels Tactic a "White Flag" Following Prolonged Equity Collapse and No Clear Recovery Plan
Calls Into Question Boards Competence Ahead of May 14 Election
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV), a global leader in AI-powered commerce, today responded to the Commerce.com, Inc. (Nasdaq: CMRC) Board of Directors adoption of a stockholder rights plan (Poison Pill or Rights Plan).
Rezolve Ai views this as a transparent attempt by a failing Board to entrench itself and prevent... More
